Correlation Between Mallinckrodt Plc and Sonoma Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mallinckrodt Plc and Sonoma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mallinckrodt Plc and Sonoma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mallinckrodt Plc and Sonoma Pharmaceuticals, you can compare the effects of market volatilities on Mallinckrodt Plc and Sonoma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mallinckrodt Plc with a short position of Sonoma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mallinckrodt Plc and Sonoma Pharmaceuticals.
Diversification Opportunities for Mallinckrodt Plc and Sonoma Pharmaceuticals
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mallinckrodt and Sonoma is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Mallinckrodt Plc and Sonoma Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonoma Pharmaceuticals and Mallinckrodt Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mallinckrodt Plc are associated (or correlated) with Sonoma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonoma Pharmaceuticals has no effect on the direction of Mallinckrodt Plc i.e., Mallinckrodt Plc and Sonoma Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mallinckrodt Plc and Sonoma Pharmaceuticals
Considering the 90-day investment horizon Mallinckrodt Plc is expected to under-perform the Sonoma Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Mallinckrodt Plc is 1.18 times less risky than Sonoma Pharmaceuticals. The stock trades about -0.74 of its potential returns per unit of risk. The Sonoma Pharmaceuticals is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 2,200 in Sonoma Pharmaceuticals on August 28, 2024 and sell it today you would lose (1,907) from holding Sonoma Pharmaceuticals or give up 86.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 4.24% |
| Values | Daily Returns |
Mallinckrodt Plc vs. Sonoma Pharmaceuticals
Performance |
| Timeline |
| Mallinckrodt Plc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Sonoma Pharmaceuticals |
Mallinckrodt Plc and Sonoma Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mallinckrodt Plc and Sonoma Pharmaceuticals
The main advantage of trading using opposite Mallinckrodt Plc and Sonoma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mallinckrodt Plc position performs unexpectedly, Sonoma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonoma Pharmaceuticals will offset losses from the drop in Sonoma Pharmaceuticals' long position.| Mallinckrodt Plc vs. Lifecore Biomedical | Mallinckrodt Plc vs. Shuttle Pharmaceuticals | Mallinckrodt Plc vs. Organogenesis Holdings | Mallinckrodt Plc vs. Journey Medical Corp |
| Sonoma Pharmaceuticals vs. China Pharma Holdings | Sonoma Pharmaceuticals vs. Universe Pharmaceuticals | Sonoma Pharmaceuticals vs. Akanda Corp | Sonoma Pharmaceuticals vs. Petros Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |